#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Selective polysaccharide antibody deficiency Hyperinsulinaemic hypoglycaemia Blastic plasmacytoid dendritic cell neoplasia Oesophageal squamous cell carcinoma stage II Hypertriglyceridaemia Gastrointestinal disorder Chronic inflammatory demyelinating polyradiculoneuropathy Head and neck cancer Macular telangiectasia Myasthenia gravis Ependymoma Cardiac amyloidosis Anal squamous cell carcinoma Wolfram syndrome Fms-like tyrosine kinase 3 positive More trials…

    Learn about Rare Diseases

    Burkitt’s lymphoma – Basic Information Congenital hypotransferrinaemia – Diagnostics Angiosarcoma – Diagnostics Idiopathic pulmonary fibrosis – Basic Information Familial haemophagocytic lymphohistiocytosis – Life with Disease Fragile X syndrome – Trials in Disease Prolymphocytic leukaemia – Treatment Behcet’s syndrome – Trials in Disease Hereditary motor and sensory neuropathy – Life with Disease Hairy cell leukaemia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Poloxamer 407 Gsk3965193B Levetiracetam Tumour Detection Raltegravir Bt-001 Betula Verrucosa Pollen Dexketoprofen Xylitol Formoterol Fumarate PUCOTENLIMAB Fluconazole BENZYDAMINE HYDROCHLORIDE SODIUM DIHYDROGEN PHOSPHATE Cerebrolysin Concentrate Cldn6 Car-T(A) Enfortumab Vedotin Follitropin Alfa Remibrutinib Emtricitabine More therapies…

    Learn about Your Condition

    Intracranial aneurysm Gastrointestinal disorder Diphtheria Langerhans' cell histiocytosis Metastases to biliary tract Haemodynamic instability Rectal cancer stage II Pyelonephritis Retinal vein occlusion Metastatic gastric cancer Head injury Noninfective chorioretinitis Univentricular heart Advanced systemic mastocytosis Cough More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effects of Risankizumab and Adalimumab in Children with Active Juvenile Psoriatic Arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Juvenile psoriatic arthritis
    Investigated Drugs:
    • Risankizumab
    • Adalimumab
    France Germany Italy Poland Spain

  • Study on Early Immunotherapy with Human Normal Immunoglobulin, Cyclophosphamide, and Methylprednisolone for Patients with Anti-Hu Paraneoplastic Sensory Neuropathy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Paraneoplastic neurological syndrome
    Investigated Drugs:
    • Methylprednisolone Hemisuccinate
    • Mesna
    • Human Normal Immunoglobulin (Iv)
    France

  • Study of AZD5305 with Abiraterone Acetate and Darolutamide in Men with Metastatic Castration-Sensitive Prostate Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer metastatic
    Investigated Drugs:
    • Abiraterone Acetate
    • Darolutamide
    • Enzalutamide
    Austria Belgium Finland France Germany Hungary +5

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy and Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Fludrocortisone Acetate
    • Opevesostat Tosilate
    • Prednisone Acetate
    Austria Czechia Denmark Finland France Germany +8

  • Study on Reducing Prosthetic Joint Infection in Hip Replacement Patients Using Vancomycin, Tobramycin, and Saline-Infused Bone Graft

    Recruiting

    2 1 1
    Investigated Diseases:
    • Medical device site joint infection
    Investigated Drugs:
    • Saline
    • Vancomycin
    Sweden

  • Study on the Safety and Dosage of GD2IL18CART for Patients with Relapsed or Refractory GD2 Positive Solid Cancers

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Clemastine Fumarate
    • Gd2Il18Cart
    • Anakinra
    Germany
Previous Page
1 … 450 451 452 453 454 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!